PHARMADUO
ActiveActs, filings and financial milestones
Deadline for the 2026 accounts:
2026
08-07
abbreviated format · 23 days before the deadline
2025
22-08
full format · 22 days late
2024
27-09
full format · 58 days late
2023
25-08
Gazette deed
Resignations: DEMAPHARMA, Marchal Sylvie and Michel DeniseAppointment: DEMAPHARMA (director) · Permanent representative: Marchal Sylvie · Amendment of the articles16 points ▸
Gazette deed
Resignations: DEMAPHARMA, Marchal Sylvie and Michel Denise
Appointment: DEMAPHARMA (director) · Permanent representative: Marchal Sylvie · Amendment of the articles16 points ▸
- General meeting, “assemblée générale extraordinaire des actionnaires, extraordinaire” (deed in French)
- Amendment of the articles, mentioned 2 times in the deed
- Legal-form conversion, “société à responsabilité limitée” (deed in French)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Reserve release, “unanimité, suppression” (deed in French)
- Capital
- Other provision, “compte de capitaux propres statutairement indisponible” (deed in French)
- General meeting, “approbation refonte statuts, unanimité des voix” (deed in French)
- General meeting, “notaire soussigné, mission au notaire soussigné d'établir et signer coordination statuts conformément décision précédente et assurer dépôt au dossier” (deed in French)
- Director resignation, DEMAPHARMA (director)
- Director resignation, Marchal Sylvie (director)
- Director resignation, Michel Denise (director)
- The act holds 4 more points.
30-05
full format · 62 days before the deadline
2022
31-12
Financial
Highest result from 2018 to 2025net €110,812 ▲2,177%
The operating result of €151,704 and the net result of €110,812 are both a record.
31-12
Financial
Equity above €200,000equity €240,001 ▲55.7%
With a profit in every financial year since 2018, equity grows to €240,001.
31-08
full format · 31 days late
2021
31-12
Financial
Weakest financial yearnet €4,866 ▼82.7%
The net result drops to €4,866, the lowest from 2018 to 2025. It recovers the following year.
31-12
Financial
Equity above €150,000equity €154,189 ▲3.3%
With a profit in every financial year since 2018, equity grows to €154,189.
26-07
full format · 5 days before the deadline
2020
30-11
full format · 122 days late
Show earlier events
2019
31-12
Financial
Equity above €100,000equity €121,248 ▲48%
With a profit in every financial year since 2018, equity grows to €121,248.
30-08
full format · 30 days late
2018
27-09
full format · 58 days late
2017
29-08
full format · 29 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
Sources:Publications in the Belgian Official GazetteFilings with the National Bank